Literature DB >> 18323494

Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans.

Andreas Gschwendtner, Stephan Ripke, Tobias Freilinger, Peter Lichtner, Bertram Müller-Myhsok, H-Erich Wichmann, Thomas Meitinger, Martin Dichgans.   

Abstract

BACKGROUND AND
PURPOSE: Genetic variation in the EPHX2 gene region has been reported to influence susceptibility to ischemic stroke in blacks. We assessed the role of this gene region in white Europeans and performed analyses with regard to stroke subtypes.
METHODS: Twenty-six single nucleotide polymorphisms in the EPHX2 gene region were genotyped in 601 patients with ischemic stroke and 736 matched controls. Cases were subtyped according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification system. Analyses were done on single markers and haplotypes using a sliding-window approach.
RESULTS: Three single nucleotide polymorphisms showed associations with an increased risk for ischemic stroke (allelic models; all P<or=0.01). One of them retained statistical significance after correction for multiple testing. Associations were observed with large-vessel stroke and stroke of undetermined etiology but not with other stroke subtypes.
CONCLUSIONS: Our findings confirm and extend previous studies suggesting that genetic variation in or near the EPHX2 gene contributes to the risk of ischemic stroke. This association seems to be mediated predominantly by large-vessel disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323494     DOI: 10.1161/STROKEAHA.107.502179

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  35 in total

Review 1.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

Review 2.  Cytochrome P450 eicosanoids and cerebral vascular function.

Authors:  John D Imig; Alexis N Simpkins; Marija Renic; David R Harder
Journal:  Expert Rev Mol Med       Date:  2011-03-01       Impact factor: 5.600

3.  Role of soluble epoxide hydrolase in age-related vascular cognitive decline.

Authors:  Jonathan W Nelson; Jennifer M Young; Rohan N Borkar; Randy L Woltjer; Joseph F Quinn; Lisa C Silbert; Marjorie R Grafe; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-09-30       Impact factor: 3.072

4.  Assessment of soluble epoxide hydrolase activity in vivo: A metabolomic approach.

Authors:  Darko Stefanovski; Pei-An Betty Shih; Bruce D Hammock; Richard M Watanabe; Jang H Youn
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-01-10       Impact factor: 3.072

5.  The differences in brain stem transcriptional profiling in hypertensive ISIAH and normotensive WAG rats.

Authors:  Larisa A Fedoseeva; Leonid O Klimov; Nikita I Ershov; Vadim M Efimov; Arcady L Markel; Yuriy L Orlov; Olga E Redina
Journal:  BMC Genomics       Date:  2019-05-08       Impact factor: 3.969

Review 6.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

7.  Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.

Authors:  Matthias J Merkel; Lijuan Liu; Zhiping Cao; William Packwood; Jennifer Young; Nabil J Alkayed; Donna M Van Winkle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

8.  Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

Authors:  Jeffrey J Iliff; Nabil J Alkayed
Journal:  Future Neurol       Date:  2009-03-01

Review 9.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

10.  Inhibition of the soluble epoxide hydrolase by tyrosine nitration.

Authors:  Eduardo Barbosa-Sicard; Timo Frömel; Benjamin Keserü; Ralf P Brandes; Christophe Morisseau; Bruce D Hammock; Thomas Braun; Marcus Krüger; Ingrid Fleming
Journal:  J Biol Chem       Date:  2009-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.